biotech pair trade

On June 22, Brean Capital analyst Jonathan Aschoff weighed in on Keryx Biopharmaceuticals Inc (NASDAQ: KERX) and Rockwell Medical Inc (NASDAQ: RMTI) to provide commentary on both companies’ dialysis drugs. Keryx Biopharmaceuticals focuses its attention on providing care for patients with...